InvestorsHub Logo
Post# of 252190
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: zipjet post# 143895

Thursday, 06/14/2012 3:04:59 PM

Thursday, June 14, 2012 3:04:59 PM

Post# of 252190

IF there is no change in the NCE, why couldn't the generic provider get approval for the new thrice weekly dose?

Teva will try and get a formulation patent.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.